OPKO Announces the Publication of Two Abstracts In the Journal of the Endocrine Society Regarding the Global Phase 3 Somatrogon Pediatric Trial

The two abstracts entitled “Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency:  Results of the Pivotal Phase 3” and “Interpretation of Insulin-like Growth Factor (IGF-1) Levels Following Administration of Somatrogon (a long-acting Growth Hormone-hGH-CTP)” have been published online in the April-May supplemental issue of the Journal of Endocrinology Society.